Un-Mainstreaming Human Enhancement
By Charles T. Rubin,
The New Atlantis
| 11. 07. 2012
America’s Grey Lady, the
New York Times, has long been willing to take transhumanist topics seriously, perhaps in some hope that she too will be somehow rejuvenated. Indeed,
a recent piece by David Ewing Duncan on human enhancement has something of the aura of a second childhood about it, with its relatively breathless and uncritical account of the various promising technologies of enhancement in the works. There follows the stock paragraph noting with remarkable brevity the safety, distributional, political and “what it means to be human” issues these developments might create, before Duncan really gets to the core of the matter: “Still, the enhancements are coming, and they will be hard to resist. The real issue is what we do with them once they become irresistible.”
Here at Futurisms, we were not unaware that human enhancements may be hard to resist. Speaking only for myself, however, I can add that there are all kinds of things I find hard to resist. It was hard to resist the desire to stay in bed this morning, hard to resist the desire...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...
Public domain portrait of James D. Watson by Cold Spring Harbor Laboratory
and the National Human Genome Research Institute on Wikimedia Commons
James Watson, a scientist famous for ground-breaking work on DNA and notorious for expressing his antediluvian opinions, died on November 6, at the age of 97. Watson’s scientific eminence was primarily based on the 1953 discovery of the helical structure of DNA, for which he, Francis Crick and Maurice Wilkins shared the 1962 Nobel Prize in Physiology or...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...